Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on April 23, 2025
Artificial Tendons and Ligaments Market Expected to Hit USD 2.7 Billion by 2035 with a Remarkable 10.46% CAGR
EIN Presswire
·
April 23, 2025
NuVasive is emphasizing innovative spinal surgical solutions and developing advanced biomaterials for artificial implants. US, NY, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Artificial Tendons and Ligaments Market Set for Strong Expansion …
Oncology Clinical Trial Market Poised to Growth USD 85.5 Billion by 2035 with Thriving CAGR of 3.84%
EIN Presswire
·
April 23, 2025
Roche is actively conducting pivotal trials for novel therapies targeting advanced breast cancer, aiming to improve treatment outcomes. US, NY, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Global Oncology Clinical Trial Market Demonstrates Steady …
Healthcare IT Integration Market Set to Grow at an Impressive CAGR of 8.88% Through 2035 | USD 11.7 Billion
EIN Presswire
·
April 23, 2025
The Healthcare IT Integration Market is characterized by a competitive landscape with a mix of established technology providers and emerging players. US, NY, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Healthcare IT Integration Market Poised for …
SynoGut Reviews (ALERT) Consumer Reports Reveal Unexpected Truths Behind Its Ingredients And Side Effects
GlobeNewswire
·
April 23, 2025
CANTON, Ohio, April 23, 2025 (GLOBE NEWSWIRE) -- SynoGut is a gut health support supplement that provides a natural way to support a healthy digestive system. The dietary formula is a combination of natural herbs, vitamins, and minerals that are clinically …
Pineal XT Reviews (WARNING) Is It Safe And Worth Trying? Understanding Its Natural Ingredients And Benefits!
GlobeNewswire
·
April 23, 2025
ALBANY, N.Y., April 23, 2025 (GLOBE NEWSWIRE) -- Pineal XT is a natural dietary capsule developed and designed to support cognitive functions. It blends in scientifically proven ingredients to enhance brain power, improve mood, stimulate the pineal gland, …
Prime Biome Reviews (We Tried It for 115 Days) Here’s Our Month-by-Month Review, Unexpected Results, And Benefits!
GlobeNewswire
·
April 23, 2025
ALBANY, N.Y., April 23, 2025 (GLOBE NEWSWIRE) -- Prime Biome is a dietary supplement designed to support skin and gut health by achieving microbial equilibrium in the body. It is loaded with probiotics for clear skin and anti-aging vitamins that can combat …
John Flack Appointed CFO of Advanced Medical Pricing Solutions
GlobeNewswire
·
April 23, 2025
PHOENIX, April 23, 2025 (GLOBE NEWSWIRE) -- Advanced Medical Pricing Solutions (“AMPS”), a diversified healthcare technology company supporting transparent, affordable medical and prescription benefits, announced today the appointment of John A. Flack II …
MJH Life Sciences® and the American College of Cardiology collaborate to advance pharmacists’ role in cardiovascular care through education and clinical collaboration
GlobeNewswire
·
April 23, 2025
CRANBURY, N.J., April 23, 2025 (GLOBE NEWSWIRE) -- MJH Life Sciences® announces a Strategic Alliance Partnership (SAP) between the American College of Cardiology (ACC) and two MJH premier brands, Pharmacy Times® (PT) and Pharmacy Times Continuing Education …
Low Apgar Score and Higher Risk of Autism Risk: Diffusion Weighted MRI
EIN Presswire
·
April 23, 2025
Low Apgar scores are linked to higher risk of Autism Spectrum Disorder, especially Autism Disorder, suggesting possible hypoxic brain injury at birth SANTA BARBARA, CA, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- “Low Apgar score has been …
Twenty Percent Recurrence of Inguinal Hernia After Polypropylene Mesh Removal
EIN Presswire
·
April 23, 2025
Up to 12% of patients may develop chronic pain after inguinal hernia mesh repair—often linked to synthetic mesh and sometimes requiring revision surgery SANTA BARBARA, CA, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- “Up to 12% of patients …
Early Pain with Coloplast Altis Single-incision Sling: Inner Leg, Groin, and Thigh
EIN Presswire
·
April 23, 2025
Altis sling linked to unique groin pain, higher sexual dysfunction rates, and study dropouts—raising safety concerns for women SANTA BARBARA, CA, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- “The Coloplast Altis 522 study and the Coloplast Altis …
AAPA 2025 Opening General Session to Explore How Technology Is Reshaping Patient Care
GlobeNewswire
·
April 23, 2025
Alexandria, Va., April 23, 2025 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA) will explore how innovation is helping medical providers address today’s top healthcare issues and improve patient outcomes during AAPA 2025’s opening …
Arvinas Announces Results from the VERITAC-2 Trial Selected as Late-Breaking Oral Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
April 23, 2025
– Oral presentation will serve as first presentation of detailed results from the Phase 3 VERITAC-2 clinical trial – NEW HAVEN, Conn., April 23, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) today announced that data from the global Phase 3 VERITAC …
SELLAS to Present at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
April 23, 2025
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
PDS Biotech Announces Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
April 23, 2025
PRINCETON, N.J., April 23, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting
GlobeNewswire
·
April 23, 2025
CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of …
Allogene Therapeutics to Present Updated ALLO-316 Clinical Results in Kidney Cancer in Oral Presentation and ALPHA3 Trial-in-Progress Poster for Cema-Cel at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
April 23, 2025
SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …
Bicara Therapeutics to Present Updated Data from Ongoing Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
April 23, 2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that updated data from …
Nexalin Technology Announces Completion of Phases One Through Five of its Virtual Clinic and Digital Ecosystem for HALO™ Clinical Research and Patient Management
GlobeNewswire
·
April 23, 2025
HOUSTON, TX, April 23, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the successful completion and launch of …
Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting
GlobeNewswire
·
April 23, 2025
FDA recently granted Breakthrough Device Designation to AVIM therapy for use in patients with uncontrolled hypertension at increased cardiovascular risk HRS Satellite Symposium will feature leading experts in electrophysiology, hypertension management and …